<!DOCTYPE html>
<html>
    <head>
        <title>STD Tx Guidelines</title>
    </head>
    <body>
        <!-- Start of page -->
        <div data-role="page" id="g276" data-theme="a">
            <div data-role="header" data-id="guidelines-header" data-theme="b" data-position="fixed">
                <a href="lv-275.html" class="ui-btn ui-icon-back ui-btn-icon-notext ui-corner-all" aria-label="back"></a>
                <h3>STD Tx Guidelines</h3>
	<a href="../menu.html" class="ui-btn ui-icon-grid ui-btn-icon-notext ui-corner-all" aria-label="main menu"></a>
            </div>
            <div data-role="content">
            <div id=guidelines_breadcrumbs>
            
                    <a href="lv-262.html" >Full Guidelines</a><span class="carrot"> > </span>
                    <a href="lv-272.html" >Diseases Characterized by Vaginal Discharge</a><span class="carrot"> > </span>
                    <a href="lv-272.html" >Trichomoniasis</a><span class="carrot"> > </span>
                    <a href="lv-275.html" >Special Considerations</a><span class="carrot"> > </span>Allergy, Intolerance, and Adverse Reactions
            </div>
            </br><h4 class="sgc-1" id="sigil_toc_id_276">
 Allergy, Intolerance, and Adverse Reactions
</h4>
<p>
 Metronidazole and tinidazole are both nitroimidazoles. Patients with an immediate-type allergy to a nitroimidazole can be managed by metronidazole desensitization in consultation&nbsp;with a specialist (364&ndash;366). Topical therapy with drugs other than nitroimidazoles can be attempted, but cure rates are low (&lt;50%).
</p>

            </div>
        </div>
        <!-- end of guidelines heading page -->
    </body>
</html>

